Claritev EBITDA 2019-2025 | CTEV

Claritev ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Claritev Annual EBITDA
(Millions of US $)
2024 $-943
2023 $598
2022 $63
2021 $810
2020 $272
2019 $768
2018 $814
Claritev Quarterly EBITDA
(Millions of US $)
2025-06-30 $129
2025-03-31 $121
2024-12-31 $71
2024-09-30 $-220
2024-06-30 $-415
2024-03-31 $-378
2023-12-31 $152
2023-09-30 $155
2023-06-30 $138
2023-03-31 $154
2022-12-31 $-507
2022-09-30 $148
2022-06-30 $202
2022-03-31 $220
2021-12-31 $225
2021-09-30 $207
2021-06-30 $194
2021-03-31 $185
2020-12-31 $61
2020-09-30 $-99
2020-06-30 $121
2020-03-31 $188
2019-12-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.135B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.991B 53.84
Tempus AI (TEM) United States $13.179B 0.00
Doximity (DOCS) United States $12.725B 56.62
Hims & Hers Health (HIMS) United States $9.572B 78.43
IRhythm Technologies (IRTC) United States $5.461B 0.00
Hinge Health (HNGE) United States $4.399B 0.00
Privia Health (PRVA) United States $2.828B 209.46
Inspire Medical Systems (INSP) United States $2.771B 40.74
Heartflow (HTFL) $2.557B 0.00
Phreesia (PHR) United States $1.884B 0.00
Enovis (ENOV) United States $1.766B 9.34
10x Genomics (TXG) United States $1.744B 0.00
Omnicell (OMCL) United States $1.497B 28.84
Schrodinger (SDGR) United States $1.436B 0.00
Azenta (AZTA) United States $1.400B 61.08
Clover Health Investments (CLOV) United States $1.343B 0.00
Evolent Health (EVH) United States $1.134B 0.00
Fulgent Genetics (FLGT) United States $0.679B 0.00
Zepp Health (ZEPP) Netherlands $0.652B 0.00
Veradigm (MDRX) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.481B 0.00
Talkspace (TALK) United States $0.445B 133.00
Butterfly Network (BFLY) United States $0.405B 0.00
Carlsmed (CARL) United States $0.354B 0.00
TruBridge (TBRG) United States $0.300B 52.53
Outset Medical (OM) United States $0.247B 0.00
Health Catalyst (HCAT) United States $0.239B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.234B 0.00
Nyxoah SA (NYXH) Belgium $0.213B 0.00
KORU Medical Systems (KRMD) United States $0.195B 0.00
CapsoVision (CV) United States $0.175B 0.00
MDxHealth SA (MDXH) Belgium $0.168B 0.00
CareCloud (CCLD) United States $0.163B 7.38
American Well (AMWL) United States $0.111B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.077B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.072B 0.00
Pulmonx (LUNG) United States $0.070B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
111 (YI) China $0.056B 0.00
HeartBeam (BEAT) United States $0.046B 0.00
Zhongchao (ZCMD) China $0.025B 0.00
Precipio (PRPO) United States $0.025B 0.00
PROFUSA (PFSA) United States $0.017B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
Bullfrog AI Holdings (BFRG) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Movano (MOVE) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00